Qualifyze
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 1.1m | 2.8m | 6.8m | 29.2m | 33.0m |
% growth | - | 150 % | 141 % | 333 % | 13 % |
Profit | - | (1.4m) | (2.8m) | - | - |
% profit margin | - | (51 %) | (41 %) | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
$1.9m | Seed | ||
€3.5m | Seed | ||
* | $14.0m | Series A | |
* | $12.0m Valuation: $70.0m | Early VC | |
* | $54.0m Valuation: $100m | Series B | |
Total Funding | $85.8m |
Recent News about Qualifyze
EditQualifyze operates in the pharmaceutical and supply chain sectors, providing comprehensive audit solutions to streamline compliance and supplier verification processes. The company serves pharmaceutical manufacturers, suppliers, and auditors by offering a vast database of GxP (Good Practice) audit reports. This database allows clients to access existing audit reports or join scheduled audits, significantly reducing the time and effort required to organize new audits. Qualifyze's platform is designed to simplify audit workflows, making it easier to secure, organize, and plan audits, thereby ensuring compliance with industry standards. The business model revolves around a subscription-based service and direct purchase options for audit reports, generating revenue through these channels. By offering a one-stop shop for all audit needs, Qualifyze enhances the efficiency and reliability of global supply chains.
Keywords: GxP audits, pharmaceutical compliance, audit database, supply chain verification, audit solutions, subscription service, audit reports, compliance management, supplier verification, audit platform.